Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
12/2008
12/24/2008WO2008070692A8 Bicyclic compounds and use as antidiabetics
12/24/2008WO2008060372A3 Thrombin receptor antagonists based on the modified tricyclic unit of himbacine
12/24/2008WO2008009077A3 4,6-dl- and 2,4,6-trisubstituted quinazoline derivatives and pharmaceutical compositions useful for treating viral infections
12/24/2008EP2005497A1 Quinoid systems as organic semiconductors
12/24/2008EP2004639A2 Processes for the synthesis of azetidinone
12/24/2008EP2004637A1 Substituted ring fused azines and their use in cancer therapy
12/24/2008EP2004636A1 Substituted enaminocarbonyl compounds used as insecticides
12/24/2008EP2004635A1 Substituted enaminocarbonyl compounds
12/24/2008EP2004634A1 3',5'-di-o-acylated nucleosides for hcv treatment
12/24/2008EP2004632A1 Hiv inhibiting 5-amido substituted pyrimidines
12/24/2008EP2004623A1 Pyridyl- and pyrimidinyl-substituted pyrrole-, thiophene- and furane-derivatives as kinase inhibitors
12/24/2008EP2004615A2 Quinazolines for pdk1 inhibition
12/24/2008EP2004607A2 New compounds
12/24/2008EP2004606A1 Substituted enaminocarbonyl compounds
12/24/2008EP1805169B1 Histamine h3 receptor inhibitors, their preparation and therapeutic uses
12/24/2008EP1601669B1 Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
12/24/2008EP1599096B1 Hetero substitued sodium channel blockers
12/24/2008EP1551804B1 Substituted 1,4-di-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists
12/24/2008EP1341786B1 Substituted derivatives of aminofuran-2-yl-acetic acid and aminothien-2-yl-acetic acid and the use thereof for treating migraines and pain
12/24/2008CN101331626A Organic electroluminescence element material and organic electroluminescence element using same
12/24/2008CN101331119A Benzoylpyrazole compounds and herbicides containing them
12/24/2008CN101331116A N-(6-membered aromatic ring)-amido anti-viral compounds
12/24/2008CN101328163A Compounds, compositions and methods
12/24/2008CN101328151A Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
12/24/2008CN101328150A 新的苯并咪唑衍生物 New benzimidazole derivatives
12/24/2008CN101328135A Carbonyl phenyl propanoic acid derivative compounds
12/24/2008CN100445276C Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
12/24/2008CN100445266C MCH antagonists and their use in treatment of obesity
12/24/2008CN100444839C Treatment of chemokine mediated diseases
12/24/2008CA2692249A1 Pyrazolone derivative and pde inhibitor containing the same as active ingredient
12/24/2008CA2692248A1 Pyridazinone derivative and pde inhibitor containing the same as active ingredient
12/24/2008CA2692170A1 Azolylmethylidenehydrazine derivative and use thereof
12/24/2008CA2690243A1 Pyrrole derivatives as p2y12 antagonists
12/24/2008CA2689208A1 Derivatives of 4-(n-azacycloalkyl) anilides as potassium channel modulators
12/24/2008CA2688441A1 Substituted aromatic heterocyclic compounds as fungicides
12/24/2008CA2687151A1 Heteroarylamide pyrimidone compounds
12/23/2008US7468444 Crystalline polymorphic dosage forms of anticholesterol agents; statins; suspending atorvastatin hemi-calcium in water for 16 hours convert the atorvastatin hemi-calcium into Form I
12/23/2008US7468443 central nervous system disorders; regenerating nervous systems
12/23/2008US7468436 Method of resolution and antiviral activity of 1,3-oxathiolane nucleoside enantiomers
12/23/2008US7468386 Pyrazole-amine compounds for the treatment of neurodegenerative disorders
12/23/2008US7468385 Preterm labor, premature birth, dysmenorrhea, inappropriate secretion of vasopressin, congestive heart failure, arterial hypertension, liver cirrhosis, nephrotic syndrome and ocular hypertension; 3-(5-((3-chlorobenzyl)sulfanyl)-4-(3-methoxypropyl)-4H-1,2,4-triazol-3-yl)-N-(2-methoxybenzyl)propanamide
12/23/2008US7468380 Nitrogen-containing aromatic derivatives
12/23/2008US7468373 Arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methods
12/23/2008US7468360 Therapeutic amides and related compounds
12/23/2008US7468177 Hydrophilic light absorbing compositions for determination of physiological function in critically ill patients
12/23/2008CA2560580C Imidazole compounds for inhibition of a.beta.-peptide production and for modulation of the notch signaling pathway
12/23/2008CA2448058C Pyrazole derivatives as hiv reverse transcriptase inhibitors
12/23/2008CA2424664C Novel non-imidazole compounds
12/18/2008WO2008154246A1 Hiv integrase inhibitors
12/18/2008WO2008153857A1 Dual-acting benzoimidazole antihypertensive agents
12/18/2008WO2008153701A1 Compounds for inhibiting ksp kinesin activity
12/18/2008WO2008152603A1 3-amino-6-(1-amino-ethyl)-tetrahydropyran derivatives
12/18/2008WO2008152332A1 Novel 4-heteroaryl-imidazole-2-thiones used as tyrosinase inhibitors, method for preparing same and use thereof in human medicine and cosmetology
12/18/2008WO2008152331A1 Novel 4-phenyl-imidazole-2-thiones used as tyrosinase inhibitors, method for preparing same and use thereof in human medicine and cosmetology
12/18/2008WO2008152223A1 Triaminopyrimidine derivatives as inhibitors of cdc25 phosphatase
12/18/2008WO2008152159A2 6 -acyloxy- 7-meth0xy- 2, 2 -dimethylchromane compounds and their use as pigmentation-regulators
12/18/2008WO2008152097A1 Cinnamic acid derivatives as modulators of the ep2 receptor
12/18/2008WO2008152094A2 Substituted acetamides as modulators of the ep2 receptor
12/18/2008WO2008152093A2 Diaminopyrimidines as modulators of the ep2 receptor
12/18/2008WO2008152014A2 3-hetrocyclylidene-indolinone derivatives as inhibitors of specific cell cycle kinases
12/18/2008WO2008151927A2 6-n-substituted benz imidazole derivatives as acid pump antagonists
12/18/2008WO2008151437A1 Heme-oxygenase inhibitors and use of the same in the treatment of cancer and diseases of the central nervous system
12/18/2008WO2008130879A3 Tetrahydroindole and tetrahydroindazole derivatives
12/18/2008WO2008130321A3 Novel n-tetrahydronaphtalene or 5-heterocyclyl-chromane or 8-heterocyclyl-tetrahydronaphtalene derivatives for the treatment of pain
12/18/2008WO2008130320A3 Novel n- (8-heteroaryltetrahydronaphtalene-2yl) or n- (5- heteroarylchromane-3-yl) carboxamide derivatives for the treatment of pain
12/18/2008WO2008130319A3 Novel n-tetrahydronaphtalene or n-chromane carboxamide derivatives for the treatment of pain
12/18/2008WO2008116139A3 N-heterocyclic compounds useful as inhibitors of janus kinases
12/18/2008WO2008100457A3 Functionally selective alpha2c adrenoreceptor agonists
12/18/2008WO2008080056A3 Pyridazinones and furan-containing compounds
12/18/2008WO2008076862A3 1-substituted imidazole derivatives and their use as aldosterone synthase inhibitors
12/18/2008WO2008067390A3 Metabolites of 5-fluoro-8-{4-[4-(6-methoxyquinolin-8-yl)piperazin-1-yl]piperidin-1-yl} quinoline and methods of preparation and uses thereof
12/18/2008US20080312455 Method For Determining Enantiomeric Purity Of Darifenacin And Intermediates
12/18/2008US20080312438 -(2-Aminopyrid-6-yl)-5-fluoro-N2-[3-(N-methylamino)carbonylmethyleneoxyphenyl]-2,4-pyrimidinediamine; signal transduction cascade inhibitor; Fc receptors for immunoglobulins IgE and IgG antagonist; autoimmune diseases, antiinflammatory agent; rheumatoid arthritis, multiple sclerosis
12/18/2008US20080312317 12 membered-ring macrolactam derivatives
12/18/2008US20080312305 Imidazoles as Gaba- B Receptor Modulators
12/18/2008US20080312299 Imidazole Derivatives as Fructose-1,6-Bisphosphatase Inhibitors and Pharmaceutical Compositions Containing Them
12/18/2008US20080312292 Antipruritics
12/18/2008US20080312273 Quinoline Derivatives Having Vegf Inhibiting Activity
12/18/2008US20080312237 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
12/18/2008US20080312221 Quinoline derivative and quinazoline derivative inhibiting self-phosphorylation of hepatocytus proliferator receptor, and medicinal composition containing the same
12/18/2008US20080312207 Compounds
12/18/2008US20080312183 3-benzoyl-1-[(Z)-4-(trityloxy)-2-butenyl]-1,2,3,4-tetrahydro-2,4-pyrimidinedione; antiprotozoa agents; Deoxyuridine triphosphate nucleotidohydrolase inhibitors; malaria
12/18/2008US20080311675 Dyes having ratiometric fluorescence response for detecting metabolites
12/18/2008US20080311076 Morpholinylanilinoquinazoline Derivatives For Use As Antiviral Agents
12/18/2008DE60224400T2 Hepatitis c virus polymerase inhibitoren mit heterobicylischer struktur Hepatitis C virus polymerase inhibitors with heterobicylischer structure
12/18/2008CA2727528A1 Heme-oxygenase inhibitors and use of the same in the treatment of cancer and diseases of the central nervous system
12/18/2008CA2691239A1 Method for determining enantiomeric purity of darifenacin and intermediates
12/18/2008CA2690567A1 New compounds
12/18/2008CA2689102A1 3-amino-6-(1-amino-ethyl)-tetrahydropyran derivatives
12/18/2008CA2688343A1 Heteroaryl-substituted urea modulators of fatty acid amide hydrolase
12/18/2008CA2688237A1 Novel 4-heteroaryl-imidazole-2-thiones used as tyrosinase inhibitors, method for preparing same and use thereof in human medicine and cosmetology
12/18/2008CA2688235A1 Novel 4-phenyl-imidazole-2-thiones used as tyrosinase inhibitors, method for preparing same and use thereof in human medicine and cosmetology
12/18/2008CA2685402A1 Triaminopyrimidine derivatives as inhibitors of cdc25 phosphatase
12/18/2008CA2684886A1 Dual-acting benzoimidazole antihypertensive agents
12/17/2008EP2003119A1 Substituted acetamides as modulators of EP2 receptors
12/17/2008EP2003118A1 Cinnamic acid derivatives as modulators of EP2 receptors
12/17/2008EP2002834A1 Aryl and hetaryl amides as modulators of EP2 receptors
12/17/2008EP2001873A1 Active ingredient combinations with insecticidal properties
12/17/2008EP2001872A1 Benzofuran compounds as ep1 receptor antagonists
12/17/2008EP2001868A1 Inhibitors of the interaction between mdm2 and p53
1 ... 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 ... 694